Testing a new botulism treatment in healthy volunteers
Treatments studied
Part of Brain & nervous system, Infections clinical trials.
This trial tests a new drug called B11-FC to prevent or treat botulism. In the first part, healthy volunteers will receive the drug to check its safety. Later, people with botulism may be included.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be between 18 and 45 years old.
- You must be in good health with no major medical problems (like diabetes, heart disease, or nerve/muscle disorders).
- You cannot have had botulism or received botulinum toxin (such as Botox) in the last 6 months.
- You must not be taking medications that weaken your immune system.
- You must be willing to use effective birth control during the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial studies how a botulism antitoxin (called BAT, heptavalent) moves through the body in children. It may help doctors better choose doses and timing for pediatric treatment by learning from blood samples after the first dose.
This trial tests a new injectable medication (Eveotox) to see if it can safely reduce arm or hand stiffness in people who have had a stroke. The goal is to improve daily activities like dressing or cleaning your hand.
This is a Phase 1 safety study testing a new investigational drug in healthy volunteers with no serious medical conditions. Researchers will give some participants the drug and others a placebo (inactive treatment) to see how safe the drug is and how the body responds to it.
This trial tests whether combining Botox with non-drug therapies (like physical therapy) helps treat spasticity, which is tight or stiff muscles. It may be a good option if your doctor has already recommended both Botox and other treatments.
This study tests an investigational botulinum toxin injection (YY001) to reduce muscle stiffness in the arm after a stroke. It may help you move your arm more easily and improve daily tasks.
This trial checks how safe BRC-002 is in healthy people and how it affects the body with and without food. It helps researchers understand the right dose and any side effects.
Hear when a new Botulism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.